BiotechTube
Home/Rallybio/Sharon Arrol, Ph.D.
SA

Sharon Arrol, Ph.D.

Head of Bioanalytical Development (inferred)

Rallybio

Therapeutic Areas

Complement DysregulationHematology

Rallybio Pipeline

DrugIndicationPhase
RLYB116Complement-mediated diseasesPhase 1

Leadership Team at Rallybio

MM
Martin Mackay, Ph.D.
Co-Founder and Chairman
SU
Steve Uden, M.D.
Co-Founder and CEO
MB
Michael Bombara
Head of Clinical Operations (inferred)
View full Rallybio profile